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Abstract
Heterotypic cell interactions are essential for the homeostasis of bone tissue, in particular the widely
studied interaction between osteoblasts and osteoclasts. Closely related with osteoclasts are monocytes/
macrophages. These have been shown to produce osteogenic factors, e.g. BMP-2, which plays a key role
in bone metabolism. However, the mechanisms through which monocytes/macrophages interact with
osteoblasts are still elusive. The aim of this work was to assess the inﬂuence of human peripheral blood
monocytes/macrophages over the early osteogenic differentiation of human bone marrow stromal cells
(hBMSCs) in the presence of dexamethasone-supplemented medium. The co-cultures were performed
using porous transwells that allowed the interaction between both cell types through the production of
paracrine factors. The potential effect of BMP-2 produced by monocytes/macrophages was addressed by
adding an anti-BMP-2 antibody to the co-cultures. hBMSCs cultured in the presence of monocytes/macro-
phages had a higher proliferation rate than hBMSCs monocultures. The quantiﬁcation of early osteogenic
marker alkaline phosphatase (ALP) revealed higher activity of this enzyme in cells in the co-culture through-
out the timeof culture. Both of these effectswere inhibited by adding an anti-BMP-2 antibody to the cultures.
Moreover, qRT–PCR for osteocalcin and osteopontin transcripts showed overexpression of both markers.
Once again, the effect of monocytes/macrophages over hBMSC osteogenic differentiation was completely
inhibited in the co-cultures by blocking BMP-2. The present report conﬁrmed that monocytes/macrophages
produce BMP-2, which promotes osteogenic differentiation and proliferation of hBMSCs cumulatively to
dexamethasone-supplemented medium. This potentially implies that monocyte/macrophages play a
stronger role in bone homeostasis than so far supposed. Copyright © 2012 John Wiley & Sons, Ltd.
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1. Introduction
It is well established that heterotypic cellular interactions
in the bone microenvironment are essential for bone
homeostasis. The demonstration that cells of the osteo-
blastic lineage control the formation and activity of
bone-resorbing cells, the osteoclasts (Rodan and Martin,
1981), is even more relevant for biologists who intend to
understand bone biology and, in particular, bone remo-
delling and regeneration. Bone formation and bone
resorption, essential for a normal bone turnover, are
coupled processes (Parﬁtt, 1982; Pirraco et al., 2009) that
co-exist within a delicate balance, controlled by factors
such as hormones (Mundy, 1993) and other growth factors
(Linkhart et al., 1996). Osteoclasts, being multinucleated
and highly specialized cells derived from the haemato-
poietic lineage that have the function of resorbing bone,
are seen as critical players in this regulatory process (Sasaki
et al., 1994; Teitelbaum et al., 1995; Teitelbaum et al., 1997).
Also from the haematopoietic lineage, and closely related to
osteoclasts, are circulating peripheral blood monocytes,
which can easily reach almost any tissue in the human
body. While in physiological conditions monocytes
differentiate into resident macrophages after tissue
inﬁltration (Hume et al., 2002), upon injury or
infection, monocytes are recruited to the injury site and
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differentiate into activated macrophages (Hume et al.,
2002) participating in the tissue response. In the particu-
lar case of bone tissue, after acquiring an inﬂammatory
phenotype, for instance at a fracture site, macrophages
can differentiate into osteoclasts (Haynes et al., 2001).
The role of monocytes/macrophages in bone remodel-
ling and regeneration certainly does not rely simply upon
this phagocytic lineage interplay. Monocytes/macro-
phages are linked to the production of several cytokines
and growth factors, such as tumour necrosis factor-a
(TNFa), transforming growth factor-b (TGFb), platelet-
derived growth factor (PDGF), ﬁbroblast growth factor
(FGF) and others (Einhorn, 1998; Dimitriou et al.,
2005). Additionally, it has been shown that macrophages
produce several osteogenic factors, such as 1,25-dihydrox-
yvitamin D3 (Kreutz et al., 1993) and BMP-2 (Champagne
et al., 2002). All these molecules have a potential effect on
other cells present at the fracture healing site, e.g. mesen-
chymal stem cells (MSCs) and osteoblastic progenitors
(Dimitriou et al., 2005). Furthermore, it is known that
activated monocytes/macrophages contribute to in vitro
vascular calciﬁcation by affecting the osteoblastic differ-
entiation of calcifying vascular cells (CVCs), a subpopula-
tion of osteoblast-like cells derived from the artery wall
(Tintut et al., 2002). Recently, some studies focusing on
bone-resident macrophages proposed a complex bone reg-
ulatory role for those cells (Chang et al., 2008; Raggatt
et al., 2009). These studies suggested that macrophages
can be key players in bone homeostasis, acting both in
bone resorption, by regulating osteoclast activity, and in
osteoblast mineralization, through cytokine production.
However, the precise effect of monocytes/macrophages
on mesenchymal progenitor cells has been subject of very
few studies, which either focus on the immunomodula-
tory effect of the MSCs (Aggarwal and Pittenger, 2005;
Jiang et al., 2005; Ryan et al., 2005) or on the osteoclastic
differentiation potential of macrophages (Udagawa et al.,
1990; Fujikawa et al., 1996; Quinn, 1998).
Bone morphogenetic protein-2 (BMP-2) is part of the
superfamily of TGFb and has been shown to induce bone
formation in vitro and in vivo (Schmitt et al., 1999a,
1999b; Valentin-Opran et al., 2002; Bessa et al., 2008).
Its potential for bone regeneration is attested by several
clinical studies involving this protein (Valentin-Opran
et al., 2002). Champagne et al. (2002) demonstrated,
in vitro, that macrophage cell lines inﬂuence the differen-
tiation behaviour of human MSCs by producing BMP-2,
which in turn triggers osteogenic differentiation. This
was an important ﬁnding, since it eventually implicates
macrophages in the process of bone healing.
The objective of this study was, therefore, to assess the
effect of human peripheral blood monocytes/macro-
phages over the osteogenic differentiation of human bone
marrow stromal cells (hBMSCs), in order to deeply under-
stand this cross-talk and to complement what was previ-
ously reported with murine and human macrophage cell
lines. For that, an indirect co-culture system, using culture
inserts, was set up with hBMSCs and human peripheral
blood-derived monocytes/macrophages under standard
osteogenic conditions in the presence of an anti-BMP-2
antibody. The use of osteogenic culture conditions
intended to further explore the effect of the culture
medium, and in particular of the dexamethasone supple-
ment, over the role of monocytes/macrophages in the
osteogenic differentiation of hMSCs.
2. Materials and methods
2.1. Cell isolation and culture
Human bone marrow aspirates (n= 4) were obtained
from routine hip revision surgeries in Hospital da Prelada
(Porto, Portugal), after informed consent. Buffy coats
(n= 4) were obtained from the Portuguese Blood Insti-
tute (IPS). All samples were acquired under cooperation
agreements with the 3Bs Research Group.
Mononuclear cells from human bone marrow samples
were obtained after homogenization of the samples and
differential centrifugation using Histopaque 1077 (Sigma,
USA). The cells were then cultured at 37 C in a humidi-
ﬁed atmosphere with 5% CO2 in Dulbecco’s modiﬁed
Eagle’s medium (DMEM; Sigma, USA), supplemented
with 10% FBS (Invitrogen, USA) and 1% antibiotics
(A/B, Invitrogen, USA). After human bone marrow stromal
cells (hBMSCs) reached conﬂuence at passage 1, 30 000 cells
were plated in 24-well culture plates and cultured in 600ml
osteogenic medium composed of DMEM plus 10% FBS and
1% A/B, and supplemented with 10mM b-glycerophosphate
(Sigma, USA), 50mg/ml ascorbic acid (Sigma, USA) and
10–8M dexamethasone (Sigma, USA) (Maniatopoulos et al.,
1988) for 24h before establishing the co-culture with
monocytes/macrophages.
Human peripheral blood mononuclear cells (hPBMNCs)
were isolated from buffy coats, following the differential
centrifugation procedure using Histopaque 1077 described
above. Monocytes/macrophages were obtained by cell
adhesion selection (Bennett and Breit, 1994). Brieﬂy, 50
000 hPBMNCs were plated in 6.5mm TranswellW inserts
with 0.4mm pore polycarbonate membrane (Corning,
USA) and left to adhere for 24h to select the monocyte/
macrophage subpopulation. After that time, non-adherent
cells were discarded and the indirect contact co-cultures
were set by placing the inserts in the 24-well culture plates
wells with the hBMSCs seeded 24h before. Both cell types
were cultured in osteogenic medium for 2, 5 and 7days.
Anti-BMP-2 antibody (Abcam, UK) was added to the
medium of half of the hBMSCs in co-culture at a dilution
of 1:100 obtained after optimization (data not shown).
Monocultures of hBMSCs in osteogenic medium were set
as controls of the assay.
2.2. Flow cytometry
After isolation, hBMSCs at passage 1 were tested for the
expression of CD45–FITC, CD73–PE and CD34–PE (all
from BD Pharmingen, USA), CD31–APC (R&D Systems,
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USA) and CD105–FITC and CD90–APC (eBiosciences,
USA) markers. The cells were resuspended in cold PBS
with 2% BSA and 100 ml cell suspension with 2105 cells,
and incubated with the antibodies at the concentration
advised by the manufacturer. After incubation for 20min
at room temperature in the dark, the cells were washed
with PBS–BSA and resuspended in PBS with 1% formal-
dehyde. Tubes were analysed in a BD FACScalibur ﬂow
cytometer (BD Biosciences, USA). Cells of interest were
gated in a forward vs side-scatter dot-plot with a linear
scale. Isotype controls were made to discern non-speciﬁc
from speciﬁc staining. A minimum of 10 000 gated events
were acquired and displayed in dot-plots created using the
Cyﬂogic software (version 1.2.1, CyFlo Ltd, Finland).
2.3. dsDNA quantiﬁcation
Proliferation of hBMSCs was assessed after total dsDNA
quantiﬁcation along the culture time. The test was
performed using the PicoGreen Quantiﬁcation Kit
(Invitrogen, CA, USA), according to the manufacturer’s
instructions, in a lysed cell suspension obtained after
osmotic and thermal shocks. Fluorescence was read in a
microplate reader (Bio-Tek, USA) at 485 ex/525 em.
2.4. Alkaline phosphatase (ALP) activity
quantiﬁcation
ALP activity quantiﬁcation was performed in the same cell
lysates used for the DNA quantiﬁcation, obtained by
osmotic and thermal shocks, and following an adapted
p-nitrophenol assay (Maniatopoulos et al., 1988). Brieﬂy,
20 ml of lysate were incubated with 80 ml p-nitrophenol
phosphate solution (0.2% w/w in diethanolamine; Sigma,
USA) at 37 C for 45min. The reaction was stopped using
80 ml 2M NaOH and 0.4mM EDTA solution. The optical
density of the samples was read at 405 nm. A calibration
curve was previously prepared using the p-nitrophenol
standards (Sigma, USA) and used to extrapolate the ALP
activity, which was then normalized against dsDNA
results.
2.5. Immunocytochemistry
After 24 h of hPBMNCs culture, the polycarbonate mem-
branes were cut off from the inserts and the selected
monocytes/macrophages were stained for CD14–FITC
monocytic lineage marker, using a mouse anti-human
monoclonal antibody (BD Pharmingen, USA) in a concen-
tration of 1:15. Non-speciﬁc binding was blocked by incu-
bation with 3% bovine serum albumin (BSA) solution in
PBS for 30min. After 1 h of incubation at room tempera-
ture, the cells were washed in PBS and counterstained
with DAPI (Invitrogen) nuclear staining.
The presence of the stromal progenitor marker STRO-1
in the hBMSCs cultured for 24 h was screened using a
mouse anti-human monoclonal antibody (Invitrogen),
diluted 1:100. Brieﬂy, after ﬁxation with formalin, the
cells were incubated with a 3% BSA solution in PBS for
30min to block non-speciﬁc binding. The cells were then
incubated with the primary antibody for 1 h at room
temperature and washed in PBS. AlexaFluor 488 secondary
antibody (Invitrogen) was incubated with the cells for 1 h
at room temperature. The cells were then washed in PBS
and counterstained with DAPI (Invitrogen) nuclear
staining.
The expression of CD14 and STRO-1 in the monocytes/
macrophages and hBMSCswas analysed using the Axioplan
Imager Z1 ﬂuorescence microscope (Zeiss, Germany).
2.6. PCR analysis
2.6.1. RNA extraction and cDNA production
mRNA of hBMSCs was extracted, after each culture time-
point, using Tri-reagent (Sigma) according to the manu-
facturer’s instructions. Brieﬂy, 800 ml TriZol were added
per 1106 cells and samples were homogenized by vigor-
ous pipetting. Following 5min incubation, 160 ml chloro-
form (Sigma) were added to each sample; the samples
were then incubated for 15min at 4 C and centrifuged
at 13 000 rpm at 4 C for 15min. After the centrifugation
the aqueous part of each sample was collected and an
equal volume of isopropanol (Sigma) was added. Follow-
ing an overnight incubation at 20 C, the samples were
centrifuged at 9000 rpm at 4 C for 10min. The superna-
tants were discarded and the pellets were washed in
ethanol, centrifuged at 9000 rpm at 4 C for 5min, and
resuspended in 12ml RNase/DNase-free water (Gibco, UK).
RNA quantity and purity were assessed using a NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies,
USA). Samples with a 260:280 ratio between 1.6 and 2.0
were used for cDNA synthesis. The cDNA synthesis was
performed using iScript cDNA Synthesis kit (BioRad, USA)
and the MiniOpticon Real-Time PCR Detection System
(BioRad). An initial amount of 2mg mRNA was used in a
total volume of 20ml RNase/DNase-free water.
2.6.2. Quantitative real-time PCR
Osteocalcin and osteopontin transcripts were quantiﬁed
in the cDNA samples, using a quantitative real-time PCR
reaction. For each sample, GAPDH was used as the house-
keeping gene. The primers were designed using Primer 3
software (version 0.4.0) and synthesized by MWG Biotech
(Germany) as follows: osteocalcin, forward 5′-GTG CAG
AGT CCA GCA AAG GT-3′, reverse 5′-TCC CAG CCA TTG
ATA CAG GT-3′; osteopontin, forward 5′-CCC ACA GAC
CCT TCC AAG TA5-3′, reverse 5′-GGG GAC AAC TGG
AGT GAA AA-3′; GAPDH, forward 5′-ACA GTC AGC CGC
ATC TTC TT-3′, reverse 5′-GAC AAG CTT CCC GTT CTC
AG-3′. A concentration of 200 nM primer was used in a
ﬁnal volume of 25 ml sample. No template controls were
included in the study as controls. The real-time PCR
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reaction was done using the iQ Syber Green SuperMix
(BioRad), following the manufacturer’s instructions, in a
MiniOpticon Real-Time PCR Detection System (BioRad).
The relative quantiﬁcation of osteocalcin and osteopon-
tin expression was performed using the 2–ΔΔCT method
(Perkin-Elmer User Bulletin No. 2). All values were ﬁrst
normalized against GAPDH values and then the co-
culture values against monoculture values.
2.7. Statistical analysis
Data were obtained from four separate experiments, with
three replicates for each condition, and averaged. Stan-
dard deviation (SD) is reported as a measure of sample
deviation. Statistical analysis was performed using
Student’s t-test for n=4 and values were considered statis-
tically signiﬁcant at p≤0.05. In the case of the quantitative
real-time RT–PCR results, the statistical analysis was
performed in ΔCT values (Yuan et al., 2006).
3. Results
3.1. Cell characterization
In what concerns hBMSCs, cells were negative for CD45,
CD34 and CD31. On the other hand, > 99% of cells
expressed the mesenchymal stem cell markers CD73,
CD90 and CD105 (Figure 1).
The selected populations, monocytes/macrophages and
hBMSCs were characterized 24 h after seeding, respec-
tively, for the expression of CD14 (Figure 2A) and
STRO-1 (Figure 2B) markers. The immunocytochemistry
results showed that the cell population isolated from the
bone marrow, albeit with different intensities between
cells, was positive for STRO-1 mesenchymal stem cells.
In addition, they also displayed a spindle-shaped mor-
phology, as observed by optical microscopy (Figure 2C),
typical of mesenchymal stem or progenitor stromal cells.
The cells selected from the hPBMNCs were, as expected,
positive for CD14.
3.2. Proliferation of hBMSCs
The effect of monocytes/macrophages on the proliferation
of hBMSCs was assessed by quantifying the dsDNA of the
hBMSCs cultures at different time points (Figure 3). The
results indicated that hBMSCs cultured in the presence
of monocytes/macrophages proliferated more than cells
in the control conditions from day 2 onward (p< 0.02).
This effect was eliminated when the co-cultures were
established in the presence of the anti-BMP-2 antibody.
For this condition, the proliferation rate of the hBMSCs
was comparable to what was determined for the hBMSC
monocultures.
3.3. Osteogenic differentiation of hBMSCs
The inﬂuence of monocytes/macrophages over the osteo-
genic differentiation of hBMSCs was assessed following
different approaches: the quantiﬁcation of the ALP activ-
ity, considered an early osteogenic marker, and the rela-
tive quantiﬁcation of the osteopontin and osteocalcin
transcripts.
The activity of the ALP enzyme on day 7 of culture was
signiﬁcantly higher (p< 0.02) in hBMSCs co-cultured
with monocytes/macrophages than in hBMSC monocul-
tures and in the co-cultures with monocytes/macrophages
in the presence of anti-BMP-2 antibody. At day 5, how-
ever, the opposite was observed; the ALP activity in both
Figure 1. Flow cytometry analysis of hBMSCs at passage 1, just before seeding, conﬁrming their progenitor phenotype
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hBMSC monocultures and co-cultures in the presence of
anti-BMP-2 antibody had signiﬁcantly higher (p< 0.02)
values than in the co-cultures. Moreover, it is worth
noting that the presence of anti-BMP-2 antibody in
the culture at day 2 was not sufﬁcient to reverse the
increased ALP activity observed in the co-culture of
hBMSCs and monocytes/macrophages. The ALP activity
in the hBMSCs co-cultured with monocytes/macrophages
in the presence of anti-BMP-2 antibody was signiﬁcantly
higher (p< 0.05) than in the hBMSCs in monoculture.
(Figure 4).
The osteogenic differentiation of the hBMSCs was
screened at the molecular level by quantifying the
osteopontin and osteocalcin expression relative to
hBMSCsmonocultures using real-time RT–PCR (Figure 5),
the results of which showed that at days 2 and 7 of
culture, the expression of osteocalcin in hBMSCs in co-
cultures had a fold change of approximately 4 (p< 0.02)
in comparison to the monoculture condition. A similar
trend was observed at day 5, although the fold change
was around 2. In contrast, the expression of osteocalcin
in hBMSCs co-cultured in the presence of anti-BMP-2
antibody was not different from what was observed for
the hBMSCs monoculture (Figure 5A). Concerning the
expression of osteopontin, an overexpression of this
gene (fold change of 1.5) was observed in hBMSCs in
co-cultures in comparison to hBMSCs in monoculture for
all times of culture. Nonetheless, these observations were
only statistically signiﬁcant (p< 0.05) at days 2 and 7. The
presence of anti-BMP-2 antibody in the cultures annulled
overexpression of the osteopontin gene, as demonstrated
by the fold change of 1 when comparing co-cultures
established in the presence of anti-BMP-2 antibody with
hBMSCs in monoculture (Figure 5B).
4. Discussion
The study of cellular interactions after bone injury and
during regeneration is of extreme importance for tissue
engineering, in the sense that it can help researchers to
better design engineered constructs and predict their out-
come when applied in the clinics. After bone injury,
monocytes are recruited to the injury site and differenti-
ate into inﬂammatory macrophages, while in normal
physiological conditions their recruitment to bone leads
to their differentiation into bone-speciﬁc macrophages
(Chang et al., 2008; Raggatt et al., 2009). Monocytes/
macrophages are also known to produce several osteo-
genic factors (Adams et al., 1985; Kreutz et al., 1993;
O’Brien et al., 1994; Champagne et al., 2002; Takahashi
et al., 2004) and several studies (Champagne et al.,
2002; Chang et al., 2008) have suggested their strong in-
ﬂuence over the osteogenic function or the differentiation
of osteoblasts. Among those different osteogenic factors is
BMP-2(Champagne et al., 2002; Chang et al., 2008).
Based on this knowledge, we hypothesized that periph-
eral blood monocytes/macrophages would also have a
signiﬁcant effect, in particular through BMP-2, over the
osteogenic differentiation of hBMSCs, the most-studied
cellular population, which has been proposed for the
construction of bone tissue-engineering constructs. The
magnitude of the monocyte/macrophage effect was further
addressed by determining whether BMP-2 and the typical
dexamethasone-containing osteogenic medium would
have a synergistic effect, over a short period of time, on
the osteogenic differentiation of hBMSCs.
In order to guarantee the validity of the work, our ﬁrst
concern was to use a progenitor cell population from the
bone marrow, intimately linked with bone tissue. More
than 95% of the isolated hBMSCs expressed CD73,
CD90 and CD105 and were negative to CD14, CD34 and
CD31 (< 2%), conforming to the accepted mesenchymal
Figure 2. Characterization of monocytes/macrophage (A) and
hBMSC (B,C) cultures after seeding. Monocyte/macrophage cul-
tures were positive for CD14 (green; A). The hBMSCs expressed
the stromal progenitor marker STRO-1 (green; B) and presented
typical ﬁbroblast-like morphology (C). Cell nuclei were counter-
stained with DAPI (blue; B)
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stem cell marker pattern. After seeding cells in the cell
culture plate wells, positivity for STRO-1 marker and
spindle-shape morphology conﬁrmed that the cells main-
tained their mesenchymal phenotype (Dominici et al.,
2006). The conﬁrmation of the monocyte/macrophage
lineage of the cells co-cultured with the hBMSCs was
demonstrated by the expression of CD14 in the cells
selected by adherence. The different intensities of expres-
sion observed after immunocytochemistry reﬂected the
different expression pattern of CD14 in monocytes and
macrophages (Zannettino et al., 2007).
Cell proliferation results showed that the presence of
monocytes/macrophages had a positive effect on hBMSC
proliferation and that this effect was inhibited by adding
anti-BMP-2 antibody. Real-time RT–PCR demonstrated
the expression of BMP-2 by monocytes/macrophages
(results not shown). This suggests that BMP-2 produced
by monocytes/macrophages is involved in promot-
ing hBMSCs proliferation. Reports in the literature
concerning the effect of BMP-2 on bone marrow stromal
cells proliferation are contradictory (Fromigué et al.,
1998; Gori et al., 1999; Lou et al., 1999), which indicates
that this effect may be highly dependent on the type of
culture model used. Some studies using hBMSCs showed
a diminished proliferation when the cells were cultured
in the presence of BMP-2 (Lecanda et al., 1998; Francesca
et al., 1999). It is also well understood how cell prolifera-
tion and differentiation are inversely regulated (Stein and
Lian, 1993). This seems to indicate that, in our model,
BMP-2 acts synergistically with other soluble factors in
the culture, resulting in proliferation of hBMSCs.
ALP activity in the co-cultures was inhibited to the level
of monocultures at days 2 and 7 of culture after BMP-2
blocking, which reveals the direct effect of BMP-2 over
ALP activity, as published by others (Lecanda et al.,
1998). The fact that for day 5 the opposite result was ver-
iﬁed could be an artifact of the experiment related to the
culture model used. This is further reinforced by the
Figure 3. Amount of dsDNA that correlates with cell number quantiﬁed along culture in hBMSCs and in co-culture with monocytes/
macrophages with (co-cultures+Ab) and without (co-cultures) anti-BMP-2 antibody; *p<0.02, relating to hBMSC cultures for the
same time point
Figure 4. Amount of hydrolysed p-nitrophenol phosphate that correlates with the ALP activity quantiﬁed along culture in hBMSCs
and in co-culture with monocytes/macrophages, with (co-cultures+Ab) and without (co-cultures) anti-BMP-2 antibody. Results were
normalized against dsDNA values. }p<0.05 and *p<0.02, relating to hBMSCs for the same time point; #p<0.02, relating to co-
cultures for the same time point
R. P. Pirraco et al
Copyright © 2012 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2012)
DOI: 10.1002/term
similar trend observed for osteopontin expression. Never-
theless, analysis of the expression of osteocalcin and
osteopontin markers conﬁrmed that the overexpression
of those markers in the presence of monocytes/macro-
phages was eliminated by blocking BMP-2. Once again,
this corresponds to what is described as the effect of
BMP-2 over the expression of osteogenic markers in
hBMSCs (Lecanda et al., 1998). Osteocalcin and osteopon-
tin are associated with the osteogenic differentiation and
mineralization processes of hBMSCs (Fromigué et al.,
1998; Lecanda et al., 1998; Gori et al., 1999), thus an over-
expression of these markers was expected.
It is also known that hBMSCs produce BMP-2 during
osteogenic differentiation (Frank et al., 2002). In the pres-
ent study, the control condition, hBMSCs monocultures in
osteogenic medium, clearly demonstrates how signiﬁcant
the presence of monocytes/macrophages is. In addition,
the effect of monocyte/macrophage-produced BMP-2
was evaluated while cells were already being directed to
the osteogenic lineage by dexamethasone-containing os-
teogenic medium. Therefore, a synergistic effect, to our
knowledge unreported so far, of BMP-2 and the
osteogenic factors in the culture medium cannot be dis-
carded. Both BMP-2 (Nishimura et al., 2002; Lian and
Stein, 2003) and dexamethasone (Phillips et al., 2006;
Mikami et al., 2007) ultimately upregulate a cascade of
osteoblastic transcription factors, among which is Runx2,
although involving two different molecular pathways. In
the case of dexamethasone, it has been proposed that its
osteogenic effect is accomplished through a glucocorti-
coid receptor-mediated mechanism that modulates Runx2
phosphorylation via mitogen-activated protein kinase
phosphatase-1 (MKP-1) (Phillips et al., 2006). On the
other hand, it is well established that BMP-2 upregulates
Runx2 via the Smad pathway (Schmitt et al., 1999a,
1999b). Therefore, it is possible that the mechanisms trig-
gered by both dexamethasone and BMP-2 have a cumula-
tive effect on the osteogenic differentiation of hBMSCs.
The mechanisms orchestrating the osteogenic differentia-
tion of hBMSCs are as complex as important to address,
even more if taking in account a possible synergistic effect
of two known osteogenic factors. It is thus our consideration
that the mechanisms proposed here should be the subject of
a more pervasive study.
Figure 5. Osteocalcin (A) and osteopontin (B) relative expressions calculated after quantitative real-time RT–PCR. The results were
ﬁrst normalized against GAPDH and then against hBMSC cultures. *p<0.02 and #p<0.05, statistically different ΔCT values in compar-
ison with hBMSCs cultures at the same time point
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5. Conclusions
The present report conﬁrms that peripheral blood mono-
cytes/macrophages are capable of deeply inﬂuencing
hBMSC metabolism. It is also strongly suggested that this
mechanism is regulated by BMP-2 production by mono-
cytes/macrophages. The effect of BMP-2 on hBMSC
differentiation was cumulative to that exerted by dexa-
methasone-containing osteogenic medium and, addition-
ally, promoted hBMSC proliferation. Synergistic effects
between dexamethasone- and BMP-2-induced effects
may explain this result, but a more profound analysis, in
both molecular and experimental time-spanning terms,
is needed.
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